StonvexLoading…
StonvexStonvexStonvexCore line items from LSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 |
|---|---|---|
Revenue | $17.79M | $18.32M |
Operating Income | $-4.96M | $-526.04K |
Net Income | $-5.25M | $-225.25K |
EPS (Diluted) | $-0.69 | $-0.04 |
Total Assets | $14.41M | $9.19M |
Total Liabilities | $11.56M | $8.55M |
Cash & Equivalents | $4.96M | $123.55K |
Free Cash Flow OCF − CapEx | $-2.70M | Not available |
Shares Outstanding | 10.50M | 6.00M |